IDEXX Laboratories, Inc. (IDXX)
Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings
Ahead of Q4 earnings, IDXX eyes double-digit revenue and EPS growth, driven by CAG momentum, new diagnostics and steady Water gains.
Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now?
IDXX rides on strong CAG Diagnostics momentum and growing global software adoption, but currency pressure and solvency risks cloud the outlook.
IDEXX Stock Up 64.7% in a Year: What's Driving the Growth?
IDXX shares surge 64.7% in a year as CAG Diagnostics momentum, strong retention and expanding software adoption fuel growth across regions.
3 ESG Stocks to Add to Your Portfolio for Sustainable Returns in 2026
NVIDIA, IDXX and Microsoft shine on ESG metrics, fueling investor interest with strong returns and ambitious 2030 goals.
Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?
Here is how Idexx Laboratories (IDXX) and Artivion (AORT) have performed compared to their sector so far this year.
3 Medical Instrument Stocks to Counter Industry Woes Using GenAI
VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.
IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge?
IDXX surges 75.6% YTD as strong CAG Diagnostics momentum and high-demand software solutions fuel growth.
Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Idexx (IDXX) Upgraded to Buy: Here's What You Should Know
Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?
Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
